Global Home Healthcare Market 2016-2020

2016-05-09
Price :
Published : May-2016
No. of Pages : 66

Home healthcare refers to a wide range of medical products (include heart rate monitors, blood glucose level indicators, and nebulizers), services, and solutions that provide health monitoring, treatment, and physical support to patients or customers at home. People do not need to visit a hospital or any other healthcare facility to benefit from these offerings; they can be accessed in the comfort of homes. The home healthcare market offers complete solutions that include the product as well as software and support from consultants and physicians.

The analysts forecast Global Home Healthcare Market to grow at a CAGR of 8.85% during the period 2016-2020.

Covered in this report

This report covers the present scenario and the growth prospects of the Global Home Healthcare Market for 2016-2020.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • Europe
  • MEA

The report, Global Home Healthcare Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Johnson & Johnson
  • Omron Healthcare
  • Philips
  • McKesson
  • Roche Holdings

Other prominent vendors

  • A&D Company
  • Abbott
  • Almost Family
  • Apria Healthcare
  • eCaring
  • Fresenius
  • Gentiva Health Services
  • Interim Healthcare
  • Kindred Healthcare
  • Linde Healthcare
  • LJC Group
  • Kinnser Software
  • Rotech Healthcare

Market driver

  • Growing demand for affordable healthcare solutions
  • For a full, detailed list, view our report

Market challenge

  • Complexity in pricing
  • For a full, detailed list, view our report

Market trend

  • Integration of mobile devices with home healthcare systems
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : Technavio
More Reports
Title Price Buy Now

Parkinson’s Disease: Epidemiology Forecast to 2026

Parkinson's Disease: Epidemiology Forecast to 2026 Summary Parkinson's disease (PD) is the second most common chronic progressive neurodegenerative disorder in the elderly, affecting 1-2% of individuals ages 65 years and older worldwide. PD is associated with motor symptoms involving bradykinesia, rest tremor, rigidity, and postural disturbances, as well as non-motor symptoms including hyposmia, rapid eye movements, sleep behavior disorder, and depression. Age, genetics, sex, and environmental exposure to pesticides increase the risk of developing PD. Conditions such as depression and anxiety have been identified as comorbidities in PD. For this analysis, GlobalData epidemiologists utilized peer-reviewed studies to construct the 10-year epidemiological forecast for the diagnosed prevale......
$3995

Paralysis Global Clinical Trials Review, H1, 2018

Paralysis Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Paralysis Global Clinical Trials Review, H1, 2018" provides an overview of Paralysis clinical trials scenario. This report provides top line data relating to the clinical trials on Paralysis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are coll......
$2500

Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H1, 2018

Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H1, 2018" provides an overview of Pelvic Inflammatory Disease (Pelvic Infections) clinical trials scenario. This report provides top line data relating to the clinical trials on Pelvic Inflammatory Disease (Pelvic Infections). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Gl......
$2500

Otitis Media Global Clinical Trials Review, H1, 2018

Otitis Media Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Otitis Media Global Clinical Trials Review, H1, 2018" provides an overview of Otitis Media clinical trials scenario. This report provides top line data relating to the clinical trials on Otitis Media. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical tri......
$2500

Paraplegia Global Clinical Trials Review, H1, 2018

Paraplegia Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Paraplegia Global Clinical Trials Review, H1, 2018" provides an overview of Paraplegia clinical trials scenario. This report provides top line data relating to the clinical trials on Paraplegia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are ......
$2500

Pemphigus Global Clinical Trials Review, H1, 2018

Pemphigus Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Pemphigus Global Clinical Trials Review, H1, 2018" provides an overview of Pemphigus clinical trials scenario. This report provides top line data relating to the clinical trials on Pemphigus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are coll......
$2500

Ovarian Cancer Global Clinical Trials Review, H1, 2018

Ovarian Cancer Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Ovarian Cancer Global Clinical Trials Review, H1, 2018" provides an overview of Ovarian Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Ovarian Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clin......
$2500

Parasitic Diseases Global Clinical Trials Review, H1, 2018

Parasitic Diseases Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Parasitic Diseases Global Clinical Trials Review, H1, 2018" provides an overview of Parasitic Diseases clinical trials scenario. This report provides top line data relating to the clinical trials on Parasitic Diseases. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trial......
$2500

Pemphigus Vulgaris Global Clinical Trials Review, H1, 2018

Pemphigus Vulgaris Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Pemphigus Vulgaris Global Clinical Trials Review, H1, 2018" provides an overview of Pemphigus Vulgaris clinical trials scenario. This report provides top line data relating to the clinical trials on Pemphigus Vulgaris. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trial......
$2500

Ovarian Disease Global Clinical Trials Review, H1, 2018

Ovarian Disease Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Ovarian Disease Global Clinical Trials Review, H1, 2018" provides an overview of Ovarian Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Ovarian Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. ......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy